Cargando…
Multicenter randomized phase II trial of prophylactic right‐half dissection of superior mesenteric artery nerve plexus in pancreatoduodenectomy for pancreatic head cancer
AIM: Right‐half dissection of the superior mesenteric artery (SMA) nerve plexus in pancreatoduodenectomy for pancreatic cancer was initiated to accomplish R0 resection; however, subsequent refractory diarrhea was a major concern. This study aimed to evaluate the necessity of this technique. METHODS:...
Autores principales: | Yamada, Suguru, Satoi, Sohei, Takami, Hideki, Yamamoto, Tomohisa, Yoshioka, Isaku, Sonohara, Fuminori, Yamaki, So, Shibuya, Kazuto, Hayashi, Masamichi, Hashimoto, Daisuke, Ando, Masahiko, Murotani, Kenta, Sekimoto, Mitsugu, Kodera, Yasuhiro, Fujii, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832966/ https://www.ncbi.nlm.nih.gov/pubmed/33532687 http://dx.doi.org/10.1002/ags3.12399 |
Ejemplares similares
-
Surgical indication for and desirable outcomes of conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma
por: Satoi, Sohei, et al.
Publicado: (2019) -
The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma
por: Sakaguchi, Tatsuma, et al.
Publicado: (2020) -
Hepatic actinomycosis after total pancreatectomy: A case report
por: Sakaguchi, Tatsuma, et al.
Publicado: (2021) -
Optimal Preoperative Multidisciplinary Treatment in Borderline Resectable Pancreatic Cancer
por: Kimura, Nana, et al.
Publicado: (2020) -
Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis
por: Yamada, S., et al.
Publicado: (2020)